Ashland Inc.
Delivering pharmaceutical and nutraceutical performance, Ashland provides solutions for applications in tablet binding, film coating and disintegration, controlled-release formulation and drug solubilization.
Delivering pharmaceutical and nutraceutical performance, Ashland provides solutions for applications in tablet binding, film coating and disintegration, controlled-release formulation and drug solubilization. Ashland creates value for customers through bioavailability enhancement, applications knowledge, regulatory support and a powerful product portfolio. We’re proud to celebrate Klucel™ hydroxypropylcellulose (HPC), a compound so versatile it changed the way the pharmaceutical industry produced oral dosage forms.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
